LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 16,688 Value ($000) $25 Avg Close $1.40 Range $1.16 - $1.58
Q3 2022
Shares 11,465 Value ($000) $13 Avg Close $1.47 Range $1.11 - $1.79
Q1 2021
Shares 17,529 Value ($000) $41 Avg Close $2.40 Range $1.55 - $3.13